Invivyd (IVVD) EV to EBIT (2021 - 2026)
Invivyd's (IVVD) quarterly EV to EBIT came in at 2.1 in Q2 2026, up 37.16% on a YoY basis from 1.53 in Q2 2025, and up 86.71% quarter-over-quarter from 15.82 in Q4 2025.
Analysis
Invivyd (IVVD) EV to EBIT (2021 - 2026) Analysis & Trends
Invivyd (IVVD) has reported EV to EBIT for 6 consecutive years, with 2.1 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to EBIT rose 37.16% year-over-year to 2.1; the trailing twelve-month figure through Jun 2026 stood at 1.14 (down 156.99% YoY), and the FY2025 full-year result was 3.58, down 3905.25% from the prior year.
- EV to EBIT rose to 2.1 in Q2 2026 per IVVD's latest filing, from 15.82 in the prior quarter.
- Across five years, EV to EBIT topped out at 2.28 in Q2 2022 and bottomed at 15.82 in Q4 2025.
- Historically, EV to EBIT has averaged 2.46 across 5 years, with a median of 1.33 in 2022.
- The widest YoY moves for EV to EBIT: up 161.58% in 2024, down 6023.25% in 2024.
- Over 5 years, EV to EBIT stood at 1.48 in 2022, then slumped by 105.07% to 3.04 in 2023, then soared by 128.43% to 0.86 in 2024, then plunged by 1930.7% to 15.82 in 2025, then soared by 86.71% to 2.1 in 2026.
- According to Business Quant data, EV to EBIT over the past three periods registered 2.1, 15.82, and 9.27 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 |
| Dec 31, 2025 | -15.82 |
| Sep 30, 2025 | -9.27 |
| Jun 30, 2025 | -3.35 |
| Mar 31, 2025 | -1.48 |
| Dec 31, 2024 | 0.86 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | -7.38 |
| Dec 31, 2023 | -3.04 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | 0.13 |
| Mar 31, 2023 | -0.12 |
| Dec 31, 2022 | -1.48 |
| Sep 30, 2022 | -1.33 |
| Jun 30, 2022 | 2.28 |
| Mar 31, 2022 | 0.32 |
| Dec 31, 2021 | 2.80 |
| Sep 30, 2021 | -34.94 |